The opportunity cost of funding new medicines: an attempt to measure the invisible

被引：0
|
作者：
Vallejo-Torres, Laura [1 ]
Vanness, David J. [2 ]
Paulden, Mike [3 ]
Claxton, Karl [4 ]
机构：
[1] Univ Las Palmas Gran Canaria, Dept Quantitat Methods Econ & Management, Las Palmas Gran Canaria, Canary Islands, Spain
[2] Penn State Univ, Dept Hlth Policy & Adm, University Pk, PA USA
[3] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada
[4] Univ York, Ctr Hlth Econ, York, England
来源：
GACETA SANITARIA | 2025年 / 39卷
关键词：
NATIONAL INSTITUTE; CARE EXCELLENCE; HEALTH;
D O I：
10.1016/j.gaceta.2025.102460
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 3 条
  • [1] A New Approach to Measure Adherence to Medicines Using Biomarkers and Sensors
    Ozdemir, Vural
    Endrenyi, Laszlo
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2019, 23 (07) : 334 - 337
  • [2] The impact of conventional cost-effectiveness analysis on pricing dynamics in the market of new medicines: a proposed countervailing approach
    Capri, Stefano
    Antonanzas, Fernando
    Levaggi, Rosella
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (04) : 431 - 438
  • [3] Development and Validation of the Perceived Interpersonal Relevancy Scales: A New Measure of Perceived Threat, Opportunity, and Invisibility Appraisals for Use Across the Adult Life Course
    Brady, Brooke
    Zheng, Lidan
    Eramudugolla, Ranmalee
    Anstey, Kaarin J.
    JOURNALS OF GERONTOLOGY SERIES B-PSYCHOLOGICAL SCIENCES AND SOCIAL SCIENCES, 2024, 79 (11):
1